Supernus and Indivior Merge: What This Means for Investors
Supernus and Indivior announce an all-stock merger, creating a formidable player in CNS biopharmaceuticals. Here's what investors need to kn…
Navigating Microsoft’s Post-Earnings Surge: Options Strategies for Traders
Microsoft's Q4 earnings have led to a surge in share price, prompting options strategies for traders looking to capitalize.
Xerox's Q2 Earnings Surprise: Navigating the Short Squeeze
Xerox's Q2 earnings beat expectations, prompting a nearly 27% surge in stock price amid a significant short squeeze.
Vertiv's 17% Stock Drop: Temporary Setback or Long-Term Concern?
Vertiv's stock plummets 17% post-earnings; CEO addresses issues that could hint at a bounce-back or deeper troubles.
Humana's Q2 Earnings Beat: Analyzing Analyst Discontent Amidst Profit Guidance
Despite beating earnings estimates, Humana faces analyst disappointment over profit guidance.
Coca-Cola's Earnings Preview: A Key Test After 19% YTD Gains
Coca-Cola's Q2 earnings report looms large, with a 19% YTD gain setting the stage for a crucial moment in the consumer staples sector.
PayPal's Q2 Earnings Beat Overshadowed by Soft Q3 Guidance
PayPal reports a Q2 earnings beat but struggles due to disappointing Q3 guidance and lack of deal updates.
Albertsons' Stock Drop: What It Means for the Consumer Staples Sector
Albertsons' lowered outlook signals potential challenges for the consumer staples sector amid weakening grocery spending.
American Airlines Cuts 2026 Earnings Outlook Amid Surge in Fuel Prices
American Airlines lowers its earnings forecast as fuel costs rise sharply, signaling potential challenges for the airline sector.
Pre-Earnings Options Play: Trader Highlights Under-the-Radar Beverage Stock
Trader Michael Khouw identifies an intriguing beverage stock as a pre-earnings opportunity, emphasizing its reward-to-risk potential.
Repligen's $1.5B BioLife Acquisition: A Game Changer in Cell Therapy
Repligen's acquisition of BioLife Solutions strengthens its foothold in the cell therapy market, promising high-margin revenue.
SpaceX Earnings Date and Lock-Up Expiration: Implications for SPCX Traders
SpaceX's first earnings report date and lock-up expiration could lead to significant volatility for traders.